GCP
TDOC icon

Gill Capital Partners’s Teladoc Health TDOC Stock Holding History

Gill Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305 Buy
+56
New +$314 ﹤0.01% 653

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gill Capital Partners's TDOC Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Teladoc Health (TDOC) in Q1 2026: 56 shares worth $305. The stake represents ﹤0.01% of the portfolio and ranks #653 among its holdings.

322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Gill Capital Partners held 56 shares of Teladoc Health worth $305 as of Q1 2026.
  • Teladoc Health was a new Gill Capital Partners position in Q1 2026.
  • Teladoc Health made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #653 holding.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.